In 1989 DuPont and giant pharmaceutical Merck and Company entered into a research and marketing arrangement. Endo began developing other drugs, although in 1983 DuPont decided to stop using the Endo name for its pharmaceutical division. By the early 1980s Endo was generating about $100 million in annual sales, hardly enough to prompt DuPont, which had more than $22 billion in annual sales at the time, to take much notice. Unfortunately Endo's marketing efforts failed to achieve the kind of growth DuPont was looking for in Symmetrel, due in large measure to the bureaucracy of the parent company. The primary reason DuPont acquired Endo was because of its marketing capabilities.
Just three years earlier DuPont had become involved in the pharmaceutical industry after one of its researchers developed an antiviral drug called Symmetrel, effective in treating flus. du Pont de Nemours & Company, better known as DuPont. The family-run business eventually relocated to Long Island, and then in 1969 was acquired by E.I. The heritage of the Endo name dates to 1920 when five brothers of the Ushkow family established Endo Laboratories, a small pharmaceutical company, in Manhattan, New York. The company is 60 percent owned by investment firm Kelso & Company. Endo markets its products to primary care physicians and specialists, as well as to other healthcare professionals and retail pharmacies. On the generic side, Endo markets Morphine Sulfate ER (extended release) tablets to treat moderate to severe pain, and Endocet, a generic equivalent to Percocet. The company also offers branded pharmaceuticals to relieve serious coughing and congestion: Hycodan, Hycomine, and Hycotuss. Endo's branded products include Percocet, using oxycodone and acetaminophen to treat moderate to moderately severe pain Percodan, using oxycodone and aspirin to treat less severe pain the Lidoderm patch, used to relieve pain caused by shingles and Frova, using frovatriptan to treat migraines. Endo develops and sells both branded and generic prescription pharmaceuticals, with its manufacturing contracted out to third parties. is a publicly traded company based in the Philadelphia, Pennsylvania area, dedicated to the niche of pain management.
NAIC: 325412 Pharmaceutical Preparation ManufacturingĮndo Pharmaceuticals Holdings Inc.
0 kommentar(er)
